SEARCH

SEARCH BY CITATION

References

  • 1
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg K, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202205, 1988
  • 2
    Steen VD, Medsger TA Jr: Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 16: 110, 1990
  • 3
    Westphal CFO: Zwei Falle Von Schlerodermie. Chariete Annalen (Berlin) 3: 341360, 1876
  • 4
    Shulman LE, Kurban AK, Harvey AM: Tendon friction rubs in progressive systemic sclerosis (scleroderma). Trans Assoc Am Physician 74: 378388, 1961
  • 5
    Steen VD, Medsger TA Jr, Rodnan GP: D-penicillamine therapy in progressive systemic sclerosis (scleroderma), a retrospective analysis. Ann Intern Med 97: 652659, 1982
  • 6
    Poole JL, Steen VD: The use of the health assessment questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 4: 2731, 1991
  • 7
    Harley J: A case of simple atrophic scleroma associated with disorder of the circulatory and pigmentary functions. Medico-Surgical Trans 60: 131137, 1877
  • 8
    Rodnan GP, Medsger TA Jr: The rheumatic manifestations of progressive systemic sclerosis (scleroderma). Clin Orthop 57: 8193, 1968
  • 9
    Blocka KLN, Bassett LW, Furst DE, Clements PJ, Paulus HE: The arthropathy of advanced progressive systemic sclerosis: a radiographic survey. Arthritis Rheum 24: 874884, 1981
  • 10
    Schumacher HR Jr: Joint involvement in PSS. Am J Clin Pathol 60: 593600, 1973
  • 11
    Medsger TA Jr: Systemic sclerosis (scleroderma), localized forms of scleroderma and calcinosis. In, Arthritis and Allied Conditions. Twelfth edition. Edited by DJMcCarty, WJKoopman. Philadelphia, Lea & Febiger, 1994
  • 12
    Seibold GR: Scleroderma (systemic sclerosis). In, Textbook of Rheumatology. Fourth edition. Edited by WNKelley, EDHarrisJr, SRuddy, CBSledge. Philadelphia, WB Saunders, 1993
  • 13
    Steen VD, Powell DL, Medsger TA Jr: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31: 196203, 1988
  • 14
    Medsger TA, Rodnan GP, Robinson H: Survival with systemic sclerosis (scleroderma): a lifetable analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75: 369376, 1971
  • 15
    Wynn G, Fineberg N, Metzer L: Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 110: 123127, 1985
  • 16
    Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, Alarcón GS, Luggen ME, Polisson RP, Willkens RF, Reading JC, Williams HJ, Ward JR: Early undifferentiated connective tissue disease. III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 118: 602609, 1993